结直肠癌筛查项目中粪便免疫化学试验阳性者的计算机断层结肠成像
在荷兰结直肠癌筛查项目中,因合并症或患者拒绝而无法行结肠镜的粪便免疫化学试验(FIT)阳性者接受计算机断层结肠成像(CTC);2014至2019年2794例FIT阳性者行CTC,检出结直肠癌160例(5.7%)、晚期肿瘤590例(21.1%),中位随访49个月发生CT后间期结直肠癌16例(0.6%),并发症5例(0.2%)。作者认为CTC的晚期肿瘤检出率低于结肠镜、CT后间期结直肠癌风险高于结肠镜,且质量报告常缺失,需建立结构化质量保证项目。
要点
- FIT阳性者行CTC检出结直肠癌160例(5.7%)、≥10 mm息肉554例(19.8%)。
- 组织学确诊晚期肿瘤590例(21.1%)、结直肠癌112例(4.0%)。
- 中位随访49个月发生CT后间期结直肠癌16例(0.6%),并发症5例(0.2%)。
核心结论
- 作者认为,与已知的结肠镜数据相比,FIT阳性筛查者行CTC的晚期肿瘤检出率较低、CT后间期结直肠癌风险较高。
- 作者指出,相当比例发生并发症,且质量报告常缺失,这凸显了在FIT阳性者中实施结构化CTC质量保证项目的必要性。
- 作者认为,需对哪些人转诊行CTC进行严格评估,并需就CTC的获益与缺陷进行沟通。
研究设计与样本
- 本研究为队列研究,纳入2014至2019年荷兰结直肠癌筛查项目中接受CTC的FIT阳性者。
- 共4506例FIT阳性者被安排行CTC(占所有FIT阳性者的1.32%),其中2794例(62%)实际接受CTC(中位年龄69岁;58.8%为男性,72.2%因合并症)。
- 数据与国家癌症登记处链接以识别CT后间期结直肠癌(PCT-CRC)。
主要发现
- 2794例接受CTC者中,检出结直肠癌160例(5.7%)、≥10 mm息肉554例(19.8%)、6至9 mm息肉512例(18.3%)。
- 因息肉≥6 mm或结直肠癌指示追加内镜检查1047例(37.5%),实际追加内镜检查987例(35.3%)。
- 组织学确诊晚期肿瘤590例(21.1%)、结直肠癌112例(4.0%)、进展期腺瘤502例(18.0%)。
- 中位随访49个月(四分位距36至64个月)期间发生CT后间期结直肠癌16例(0.6%),并发症5例(0.2%)。
- 质量报告常缺失。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出与结肠镜相比CTC的晚期肿瘤检出率较低而CT后间期结直肠癌风险较高。
- 作者指出质量报告常缺失。
- 作者指出需建立结构化质量保证项目并进一步评估转诊CTC的人群及沟通获益与缺陷。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: In the Dutch colorectal cancer (CRC) screening program, fecal immunochemical test (FIT)-positives are offered computed tomography colonography (CTC) instead of colonoscopy in case of comorbidities or patient refusal. Literature on CTC in FIT-positives is scarce, and the risk of post-CT interval CRC (PCT-CRC) in this population is unknown. METHODS: In this cohort study, we assessed CTC yield, clinical management, and risk of PCT-CRC in FIT-positives who underwent CTC between 2014 and 2019 in the Dutch CRC screening program. Data were linked with the National Cancer Registry to identify PCT-CRCs. RESULTS: Of 4506 FIT-positives scheduled for CTC (1.32% of all FIT-positives), 2794 (62%) underwent CTC (median age, 69 years; 58.8% male, 72.2% due to comorbidities). CRC was detected in 160 (5.7%), polyps ≥10 mm in 554 (19.8%), and polyps 6 to 9 mm in 512 (18.3%). A total of 1047 additional endoscopies (37.5%) were indicated for polyps ≥6 mm or CRC. A total of 987 additional endoscopies (35.3%) were performed. Histologically confirmed advanced neoplasia (AN) was present in 590 (21.1%), CRC in 112 (4.0%), and advanced adenomas in 502 (18.0%). Sixteen PCT-CRCs (0.6%) occurred during a median follow-up of 49 months (interquartile range, 36-64 months). Quality reporting was often lacking, and 5 complications (0.2%) occurred. CONCLUSIONS: CTC in FIT-positive screenees was associated with a lower AN detection rate and a higher PCT-CRC rate compared with what is known from colonoscopy. A substantial proportion of complications occurred, and quality reporting was often lacking. This underlines the need for a structured quality assurance program for CTCs performed in FIT-positives. Critical appraisal of who to refer for CTC and communication about the benefits and pitfalls of CTC are warranted.
引用
- Moen S, Marijnissen FE, Terhaar Sive Droste JS, et al. Computed Tomography Colonography in Fecal Immunochemical Test Positives in a Colorectal Cancer Screening Program. Clin Gastroenterol Hepatol. 2025. PMID: 40345412. doi:10.1016/j.cgh.2025.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。